Prilenia Investigational Site (Site 333) — Washington D.C., District of Columbia

Prilenia Investigational Site (Site 333) is a clinical research site located in Washington D.C., District of Columbia, United States 20057.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Prilenia Investigational Site (Site 333) has participated in 1 clinical trials.

Therapeutic areas: Huntington Disease.

Sponsors: Prilenia.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Prilenia Investigational Site (Site 333)?

Prilenia Investigational Site (Site 333) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Prilenia Investigational Site (Site 333) conducted?

Prilenia Investigational Site (Site 333) has 1 clinical trials on record. Their work covers Huntington Disease.

Is Prilenia Investigational Site (Site 333) accredited by Crixeo Health?

Prilenia Investigational Site (Site 333) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Prilenia Investigational Site (Site 333)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.